Premium
Back Cover: The Integrin Ligand c (RGDf( N Me)Nal) Reduces Neointimal Hyperplasia in a Polymer‐Free Drug‐Eluting Stent System (ChemMedChem 7/2014)
Author(s) -
Rechenmacher Florian,
Steigerwald Kristin,
Laufer Burkhardt,
Neubauer Stefanie,
Kapp Tobias G.,
Li Liang,
MasMoruno Carlos,
Joner Michael,
Kessler Horst
Publication year - 2014
Publication title -
chemmedchem
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.817
H-Index - 100
eISSN - 1860-7187
pISSN - 1860-7179
DOI - 10.1002/cmdc.201490027
Subject(s) - neointimal hyperplasia , ligand (biochemistry) , integrin , chemistry , drug , hyperplasia , stent , cancer research , medicine , pharmacology , cell , receptor , biochemistry , restenosis
The back cover picture shows the release of the peptidic integrin ligand c (RGDf( N Me)Nal) from a polymer‐free drug‐eluting stent to inhibit smooth muscle cell proliferation and as a consequence to reduce neointimal hyperplasia. For more details, see the Full Paper by Horst Kessler et al. on p. 1413 ff.